News Digest /
Lukas Schmidt
Author: Lukas Schmidt
03:51am, Tuesday, Aug 20, 2024
Alaska Airlines (NYSE: ALK) has cleared a key regulatory hurdle for its $1.9 billion merger with Hawaiian Airlines (NASDAQ: HA) after the DOJ concluded its investigation. This development could open new opportunities for investors as the airlines expand their networks.
03:48am, Tuesday, Aug 20, 2024
Northvolt is shifting its R&D operations back to Sweden from California, aiming to enhance productivity amid recent challenges. This strategic move could boost its lithium-metal technology and position it favorably in the electric vehicle market, making it a stock to watch.
09:46am, Monday, Aug 19, 2024
Celcuity Inc. (NASDAQ: CELC) reported a Q2 2024 net loss of $23.7M, up from $14.6M last year. Despite challenges, the biotech firm is advancing gedatolisib in crucial trials and raised $129M for future initiatives, positioning for potential growth in the cancer treatment market.
08:47am, Monday, Aug 19, 2024
Liquidia Corporation (NASDAQ: LQDA) faced a 40% stock drop after the FDA delayed approval for its inhaled drug yutrepia due to United Therapeutics' exclusivity on Tyvaso DPI. The situation highlights the volatility in biopharma investments amid patent disputes.
07:31am, Monday, Aug 19, 2024
ZIM Integrated Shipping Services (NYSE: ZIM) exceeded Q2 earnings expectations with EPS at $3.08, beating forecasts by $1.30. Revenue also rose to $1.93 billion, signaling strong demand. The stock has gained 53.71% over the past year, attracting investor interest.
06:25am, Monday, Aug 19, 2024
B. Riley Financial (NASDAQ: RILY) shares fell 8.6% in premarket trading after a tumultuous week, following a 65.5% drop that left them at a decade low. Co-CEO Bryant Riley's buyout attempt offers little solace amid SEC scrutiny and potential Q2 losses.
05:59am, Monday, Aug 19, 2024
XPeng Inc. (NYSE: XPEV) shares dipped 1% after Q3 revenue guidance fell below expectations. While Q2 showed improvement with a smaller loss and decent revenue, the outlook for Q3 is less optimistic. Investors are wary as vehicle delivery targets are missed.
05:29am, Monday, Aug 19, 2024
Nvidia (NASDAQ: NVDA) is set to announce its fiscal Q2 2025 earnings on August 28, with Wall Street optimistic about strong demand for its GPUs crucial for AI applications. Despite potential Blackwell chip delays, analysts expect solid Data Center growth. Goldman Sachs maintains a Buy rating with...
05:03am, Monday, Aug 19, 2024
Eli Lilly's Zepbound, a groundbreaking GLP-1 agonist, is quickly becoming a blockbuster, complementing Mounjaro and competing with Novo Nordisk. With the obesity treatment market expected to reach $100 billion by 2030, Eli Lilly is a compelling long-term investment.
04:55am, Monday, Aug 19, 2024
MTY Food Group (OTC: MTYFF) presents a solid investment opportunity amid market volatility. Known for strategic acquisitions and robust cash flow, it offers a 2.5% dividend yield and is potentially undervalued. Aiming for steady growth, MTY is a smart choice for traders.
04:44am, Monday, Aug 19, 2024
Plus500 (LON: PLUSP) shares rose 4.4% after a strong Q2 report, revealing increased guidance and robust financials. With a $185.5M shareholder return and a debt-free balance sheet, analysts maintain a "buy" rating, eyeing growth in Japan and the US.
07:03am, Wednesday, Aug 14, 2024
Elbit Systems (NASDAQ: ESLT) reported a strong Q2 EPS of $1.76, exceeding forecasts by $0.17 and generating $1.63 billion in revenue. Despite recent stock declines, positive EPS revisions signal potential for future growth. Traders should watch upcoming earnings closely.
05:34am, Wednesday, Aug 14, 2024
Mars, Inc. is set to acquire Kellanova (NYSE: K) for nearly $30 billion, marking its largest buy to date. This strategic move aims to strengthen its snack portfolio amidst market pressures, potentially impacting stock prices and broader industry trends.
04:25am, Wednesday, Aug 14, 2024
Intel (NASDAQ: INTC) divested 1.18 million shares of Arm Holdings, netting $146.7M to enhance liquidity amid a challenging chip market. Facing job cuts and halted dividends, Intel shifts focus to AI chip development, while managing rising costs and declining stock value.
Sign In